Products and Services for Cell and Gene Therapy –
From Discovery to Commercialization

Therapeutic, serum-free cell-culture media enabling robust, consistent and cost-efficient processes for cell and gene therapies.

Research grade hematopoietic, immune and stem cells with related media, from immediately available cryopreserved cells to made-to-order fresh whole tissue.

An electroporation-based transfection platform for the non-viral, ex-vivo genetic modification of human primary cells. Ranging from small to large scale formats, allowing you to easily translate research results into therapeutic applications.

An extensive service offering that includes tailored process and analytical development, cGMP manufacturing, and regulatory services.

The Bacterial Endotoxin Test (BET) is a crucial safety requirement for end-product release. Our regulatory compliant BET products and services ensure your cell therapies can be used with confidence.

A configurable and flexible electronic batch record solution for paperless data capture in laboratories and manufacturing facilities with GMP compliance and tracking at its core.

A functionally closed and automated platform for cell therapy manufacturing, providing flexibility and scalability to your process and allowing you to substantially reduce costs.

Download our free brochure and discover how teaming up with one experienced partner can help you to successfully navigate the path from early discovery to commercialization.

Learn from Senior Scientist Jerome Jacques how Lonza's new TheraPEAK^TM SfAAV^TM Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

Learn how a functionally-closed and automated non-viral workflow can help you reduce costs and improve process efficiencies.